Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 858,000 | 1,060,000 | 924,000 | 863,000 | 692,000 |
| Receivables | 186,000 | 192,000 | 327,000 | 310,000 | 257,000 |
| Inventories | 93,000 | 73,000 | 78,000 | 52,000 | 41,000 |
| Other current assets | 50,000 | 35,000 | 0 | 0 | 0 |
| TOTAL | $1,187,000 | $1,360,000 | $1,329,000 | $1,225,000 | $990,000 |
| Non-Current Assets | |||||
| PPE Net | 60,000 | 60,000 | 57,000 | 54,000 | 27,000 |
| Intangibles | 62,000 | 72,000 | 84,000 | 92,000 | 83,000 |
| Other Non-Current Assets | 222,000 | 160,000 | 77,000 | 73,000 | 109,000 |
| TOTAL | $344,000 | $292,000 | $218,000 | $219,000 | $219,000 |
| Total Assets | $1,531,000 | $1,652,000 | $1,547,000 | $1,444,000 | $1,209,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,000 | 4,000 | 4,000 | 5,000 | 101,000 |
| Accounts payable and accrued liabilities | 524,000 | 623,000 | 721,000 | 665,000 | 658,000 |
| Other current liabilities | 48,000 | 71,000 | 69,000 | 143,000 | 219,000 |
| TOTAL | $599,000 | $742,000 | $818,000 | $854,000 | $1,030,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 230,000 | 233,000 | 237,000 | 477,000 | 434,000 |
| Other Non-Current Liabilities | 620,000 | 468,000 | 426,000 | 316,000 | 40,000 |
| TOTAL | $850,000 | $701,000 | $663,000 | $793,000 | $474,000 |
| Total Liabilities | $1,449,000 | $1,443,000 | $1,481,000 | $1,647,000 | $1,504,000 |
| Shareholders' Equity | |||||
| Common Shares | 73,000 | 73,000 | 73,000 | 72,000 | 72,000 |
| Retained earnings | 1,311,000 | 1,449,000 | 1,315,000 | 1,032,000 | 950,000 |
| Other shareholders' equity | -1,308,000 | -1,318,000 | -1,327,000 | -1,309,000 | -1,317,000 |
| TOTAL | $82,000 | $209,000 | $66,000 | $-203,000 | $-295,000 |
| Total Liabilities And Equity | $1,531,000 | $1,652,000 | $1,547,000 | $1,444,000 | $1,209,000 |